Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/ Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial